The Indiana University School of Medicine is a medical school and medical research center connected to Indiana University; its principal research and medical center is on the Indiana University – Purdue University Indianapolis campus in Indianapolis.
The medical school awarded the Doctor of Medicine (M.D.) degree to its first class in 1907. With more than 2,000 students in 2013, it is currently the second largest medical school in the United States (the largest is the University of Illinois College of Medicine). The School offers several joint-degree programs, including an MD/MBA, MD/MA, MD/MPH, and an NIH-designated Medical Scientist Training Program, a highly competitive subset of MD/PhD programs. For the 2012 entering class, there were 335 students enrolled in the MD program.
The school is a pioneer in cancer, immunology, alcohol, neuroscience, and diabetes (see section below). Notably, some of its recent research discoveries that have received international acclaim include a curative therapy in testicular cancer made by patient Lance Armstrong, the cardiac ultrasound technology, several genes linked to Alzheimer’s, the link between mind and body health, the development of neuronal stem cells, and tautomycetin as a potentially new anti-cancer drug. The School of Medicine possesses an NCI—designated Clinical Cancer Center, the only NIH—funded viral vector production facility for clinical grade therapeutics, and one of three Centers of Excellence in Molecular Hematopoiesis in the nation.
The Latest Updated Research News:
Indiana University School of Medicine research articles from Innovation Toronto
- Telecare Intervention Improves Chronic Pain – July 20, 2014
- Novel Technology Seen as New, More Accurate Way to Diagnose and Treat Autism
- Could a NOSH-Aspirin-a-Day Keep Cancer Away?
- System ‘prints’ precise drug dosages tailored for patients
[divide icon=”square” margin_top=”50″ margin_bottom=”50″ width=”medium” color=”#2f23d